Trans-stilbene compounds were also identified as GLYI inhibitors, among which piceatannol is the most potent (IC50 =0.76 μM), also showing the ability to inhibit the proliferation of human lung cancer NCI-H522 cells [33]. Here, GLO1 is linked to lung carcinoma.